CoChat

Chloride channel diseases resulting from impaired transepithelial transport or vesicular function

Open access
Jentsch, T. J. · 2005 · Journal of Clinical Investigation
Cited by 142

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The transport of anions across cellular membranes is crucial for various functions, including the control of electrical excitability of muscle and nerve, transport of salt and water across epithelia, and the regulation of cell volume or the acidification and ionic homeostasis of intracellular organelles.Given this broad range of functions, it is perhaps not surprising that mutations in Cl -channels lead to a large spectrum of diseases.These diverse pathologies include the muscle disorder myotonia, cystic fibrosis, renal salt loss in Bartter syndrome, kidney stones, deafness, and the bone disease osteopetrosis.This review will focus on diseases related to transepithelial transport and on disorders involving vesicular Cl -channels. Defects in transepithelial Cl -transportAs Cl -channels allow only for the passive, diffusional flux of Cl -down its electrochemical gradient, the difference between cytoplasmic and extracellular Cl -concentration ([Cl -]), together with the membrane voltage, determines whether the opening of a Cl -channel will lead to an influx or efflux of this ion.Whereas in adult neurons intracellular [Cl -] ([Cl -] i ) is mostly below its equilibrium (predominantly because of the activity of the neuronal potassium chloride cotransporter KCC2; ref. 1), [Cl -] i in epithelial cells is often in the 30-40 mM range and thus above equilibrium at a voltage (-50 mV) typical for these cells.Several cotransporters may contribute to the relatively high cytoplasmic [Cl -] i in epithelia, most prominently NaK2Cl cotransporters.Opening of epithelial Cl -channels will therefore lead mostly to an efflux of Cl -, and the localization of these channels will determine the transport direction (Figure 1).Hence, apical Cl -channels are involved in Cl -secretion (as shown in Figure 1B), whereas basolateral Cl -channels play a role in Cl -(and salt) (re)absorption (Figure 1D). CFTR and cystic fibrosisCystic fibrosis is the most common and best-known genetic disease involving a defect in transepithelial Cl -transport.It affects several epithelial organs, i.e., the lungs, pancreas, and intestine, among others.The most serious cystic fibrosis symptoms are generally observed in the lungs, where the fluid covering the airway epithelia becomes viscous and susceptible to bacterial infection.CFTR, the cystic fibrosis transmembrane conductance regulator (2), functions as a cAMP-and ATP-regulated Cl -channel.This discovery came as a surprise, because CFTR belongs to the gene family of ABC transporters, which normally function as transport ATPases, but not as ion channels.However, the line separating ion channels from transporters may be thin, as recently demonstrated (3) by the 2Cl -/H + exchange activity of a bacterial homolog of mammalian Cl - channels of the CLC gene family.In addition to the well-established function of CFTR as a Cl -channel, many regulatory roles have been ascribed to it, but some of these remain controversial (4-6).CFTR may negatively regulate the epithelial Na + channel ENaC, the activation of which may contribute to the cystic fibrosis lung phenotype (4, 7).However, the purported interaction of both channels was questioned by others (8).Recent data indicate that CFTR may directly activate the anion exchangers Slc26a3 (DRA, downregulated in adenoma) and Slc26a6 (PAT-1) (9).Certain CFTR mutations identified in patients may impair the Cl -/HCO 3 -exchange activity of these transporters (9) and thus could result in decreased pancreatic HCO 3 -secretion as is often observed in cystic fibrosis.The role of CFTR in lung physiology is complex, and the cystic fibrosis lung pathology is not reproduced in mouse models.By contrast, the role of CFTR in colonic Cl -secretion is well understood (Figure 1B).In the colon, CFTR expression seems to be limited to crypts (10), which are the site of Cl -secretion (11).Like in other epithelia and consistent with a secretory role, CFTR is present in the apical membrane of the crypt cells.The opening of CFTR Cl -channels, which is triggered by a rise in cAMP, leads to a passive efflux of Cl -because [Cl -] i is elevated above equilibrium by the activity of basolateral NKCC1 NaK2Cl cotransporters.K + ions that are taken up together with Cl -in a stoichiometrically coupled process need to be recycled through basolateral K + channels that are most likely heteromers of KCNQ1 and KCNE3 subunits (12), which are coexpressed in crypt cells (12, 13).As predicted by this model (Figure 1B), the disruption of CFTR in cystic fibrosis impairs colonic Cl -and fluid secretion.This results in thick feces (meconium ileus) in a subset of infants suffering from cystic fibrosis.Similar intestinal problems are the major phenotype observed in CFTR mouse models (14).Conversely, inadequately strong activation of CFTR by the drastic increase in cAMP that is elicited by cholera toxin leads to severe diarrhea, which can be alleviated in animal models by blocking of the basolateral K + conductance (12,15).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci25470

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 142

Metadata

Authors
Jentsch, T. J.
Venue
Journal of Clinical Investigation
Published
2005-08-01
Volume
115
Issue
8
Pages
2039-2046
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2025328520
Cited by
142
References
2
FWCI
4.15
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.